Author

Y. M. Vasiliev

Observed names: Iu M Vasiliev, Yu M Vasiliev, Yu. M. Vasiliev, Yuri M Vasiliev, Yuri Vasiliev, Ю. М. Васильев

Observed institutions: Russian Academy of Sciences, R-Pharm (Russia), State Research Institute of Highly Pure Biopreparations, Research Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences, Federal Research Centre «Fundamentals of Biotechnology» of the Russian Academy of Sciences

ORCID: 0000-0002-2517-1776

Observed ORCID: 0000-0002-2517-1776

OpenAlex ID: A5013571595

Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation

2014 · Yuri M Vasiliev · Expert Review of Vaccines · 75

Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally

2009 · Yuri Ghendon, Stanislav Markushin, et al. · Journal of Medical Virology · 69

Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy

2023 · Nikolai Nikitin, Yuri Vasiliev, et al. · Vaccines · 20

PDF

Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision‐making and communication

2020 · Rosalind Hollingsworth, Clotilde El Guerche‐Séblain, et al. · Influenza and Other Respiratory Viruses · 20

PDF

Wuhan Sequence-Based Recombinant Antigens Expressed in E. coli Elicit Antibodies Capable of Binding with Omicron S-Protein

2024 · Ekaterina Evtushenko, Ekaterina Ryabchevskaya, et al. · International Journal of Molecular Sciences · 3

PDF

Comparative Immunogenicity Evaluation of Characterized Chitosan-Based and Other Adjuvants for Inactivated Influenza Vaccines

2016 · L. M. Khantimirova, O. S. Kashirina, et al. · Epidemiology and Vaccinal Prevention · 2

PDF

[adjuvanted Influenza Vaccines: Data From Direct Comparative Studies].

2015 · M I Chernikova, Yu M Vasiliev · PubMed · 2

[comparative Immunogenicity Studies of Adjuvants From Various Sources and With Different Mechanisms of Action for Inactivated Influenza Vaccines].

2015 · M I Chernikova, O S Kashirina, et al. · PubMed · 1

[comparative Study of Immunogenicity and Protective Effect of Live Cold-adapted and Inactivated Vaccines Against Type a Influenza].

2015 · O S Kashirina, M I Chernikova, et al. · PubMed · 1

[Problem of influenza prophylaxis by vaccines].

2011 · Iu Z Gendon, Iu M Vasiliev · PubMed · 1

Preclinical valuation of immunogenicity and effectiveness of inactivated cultural vaccine experimental patterns against coronaviral infection COVID-19

2026 · N. K. Cherniкova, D. A. Kutaev, et al. · Epidemiology and Vaccinal Prevention

PDF

Adenovirus Serotype 26 Cultivation on a Production Scale: Optimization of Conditions

2025 · A. V. Kirilin, E. A. Guzov, et al. · Applied Biochemistry and Microbiology

Культивирование аденовируса 26 серотипа в производственном масштабе: оптимизация условий

2024 · А. В. Кирилин, Е. А. Гузов, et al. · Biotekhnologiya

Control of Influenza Via Vaccines: Challenges and Perspectives as Viewed by Various Stakeholders

2018 · Y. M. Vasiliev · Russian Journal of Infection and Immunity

PDF

Challenges in development of chitosan-based adjuvants for influenza vaccines

2016 · Yuri Vasiliev · Journal of Infectious Diseases and Therapy

Immunogenicity and Protective Effect of Live Cold-Adapted Vaccines against Influenza B after Intranasal Immunization of Mice

2015 · O. S. Kashirina, Y. M. Vasiliev · Epidemiology and Vaccinal Prevention

PDF

Works count: 16

Citation count: 194

H-index: 4

I10-index: 4